Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2018) 59 EP29 | DOI: 10.1530/endoabs.59.EP29

Lancashire Teaching Hospital, Chorley, UK.


A 48 year-old lady was referred to Endocrinology clinic in November 2016 with symptoms of tiredness and lethargy for two months. Routine bloods were unremarkable, apart from an incidental finding of raised Vitamin D:258 nmol/l(NR: 50–150). She had depression and was otherwise fit & well. She was on Citalopram and combined oral contraceptive pill (Microgynon). She denied any excessive sun exposure. She didn’t drink any milk, only drank orange juice. She took multivitamins in 2016, but stopped it in summer time. Examination was unremarkable. Investigations revealed normal full blood count, bone, kiney, liver function, inflammatory markers, thyroid, parathyroid hormones, Viamin B12, Folate, Ferritin, HbA1c, angiotensin converting enzyme, lipid profile and renal ultrasound. Urine calcium excretion was 2.4mmol/24h (NR:2.5–7.5). Dual-Energy-X-ray-Absorptiometry (DEXA) showed moderately low spine density with moderate fracture risk. Vitamin D remained persistently high from 220–258 nmol/l from June 2016 to March 2017. Hypervitaminosis D secondary to oestrogen-containing-contraceptive-pill was suspected; we changed Microgynon (ethinylestradiol with levonorgestrel) to progesterone only pill (Desogestrel) in March 2017. Repeat Vitamin D in October 2017 was normal(134 nmol/l). Recent Vitamin D was also normal(104 nmol/l) in April 2018. The majority of hypervitaminosis D cases in literature are related to prescribing or manufacturing errors and increased use of over the counter multivitamins, rarely leading to vitamin D toxicity. One of the known culprits is the oestrogen-containing-contraceptive-pill. An American study in 2016 (1662 women) showed 20% increase in vitamin D levels in women using oestrogen-containing-contraception-pill. Although there is a clear link, the biological pathway behind this association is not well understood; possibly, changes in the metabolism of vitamin D in women taking oestrogen-containing-contraception-pill and rarely leading to toxic levels, unlike our patient who reached toxic levels and subsequently reverted back to normal vitamin D levels after discontinuing the oestrogen pill.

Volume 59

Society for Endocrinology BES 2018

Glasgow, UK
19 Nov 2018 - 21 Nov 2018

Society for Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.

My recently viewed abstracts